Header Logo

Connection

Shabir Madhi to Carrier State

This is a "connection" page, showing publications Shabir Madhi has written about Carrier State.
Connection Strength

7,874
  1. Bacterial nasopharyngeal carriage following infant immunization with pneumococcal conjugate vaccines according to a 2+1 schedule in children in South Africa: an exploratory analysis of two clinical trials. Expert Rev Vaccines. 2020 12; 19(12):1177-1189.
    View in: PubMed
    Score: 0,689
  2. Evaluation of the impact of HIV-1 infection and density of common nasopharyngeal bacterial colonizers in South African children immunized with 7-valent pneumococcal conjugate vaccine. Vaccine. 2020 02 11; 38(7):1762-1769.
    View in: PubMed
    Score: 0,643
  3. Molecular Subtyping of Human Rhinovirus in Children from Three Sub-Saharan African Countries. J Clin Microbiol. 2019 09; 57(9).
    View in: PubMed
    Score: 0,628
  4. Comparison of traditional culture and molecular qPCR for detection of simultaneous carriage of multiple pneumococcal serotypes in African children. Sci Rep. 2017 07 05; 7(1):4628.
    View in: PubMed
    Score: 0,542
  5. The potential impact of pneumococcal conjugate vaccine in Africa: Considerations and early lessons learned from the South African experience. Hum Vaccin Immunother. 2016; 12(2):314-25.
    View in: PubMed
    Score: 0,488
  6. Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine. Vaccine. 2015 May 28; 33(23):2662-9.
    View in: PubMed
    Score: 0,465
  7. Natural acquired humoral immunity against serotype-specific group B Streptococcus rectovaginal colonization acquisition in pregnant women. Clin Microbiol Infect. 2015 Jun; 21(6):568.e13-21.
    View in: PubMed
    Score: 0,459
  8. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age. Vaccine. 2015 Jan 29; 33(5):628-34.
    View in: PubMed
    Score: 0,454
  9. Temporal association of infant immunisation with pneumococcal conjugate vaccine on the ecology of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonisation in a rural South African community. Vaccine. 2014 Sep 22; 32(42):5520-30.
    View in: PubMed
    Score: 0,442
  10. Temporal changes in pneumococcal colonization in a rural African community with high HIV prevalence following routine infant pneumococcal immunization. Pediatr Infect Dis J. 2013 Nov; 32(11):1270-8.
    View in: PubMed
    Score: 0,420
  11. Interrelationship of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus colonization within and between pneumococcal-vaccine naïve mother-child dyads. BMC Infect Dis. 2013 Oct 17; 13:483.
    View in: PubMed
    Score: 0,419
  12. Acquisition of Streptococcus pneumoniae in pneumococcal conjugate vaccine-naïve South African children and their mothers. Pediatr Infect Dis J. 2013 May; 32(5):e192-205.
    View in: PubMed
    Score: 0,405
  13. Single priming and a booster dose of 10-valent and 13-valent pneumococcal conjugate vaccine (PCV) maintains suppression of vaccine serotype colonization in South African children at 3, 4, and 5 years of age: a single-centre, open-labelled, randomized trial. Expert Rev Vaccines. 2024 Jan-Dec; 23(1):1011-1019.
    View in: PubMed
    Score: 0,225
  14. Bacterial nasopharyngeal colonisation in children in South Africa before and during the COVID-19 pandemic: an observational study. Lancet Microbe. 2024 01; 5(1):e34-e42.
    View in: PubMed
    Score: 0,211
  15. Streptococcus pneumoniae and other bacterial nasopharyngeal colonization seven years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children. Int J Infect Dis. 2023 Sep; 134:45-52.
    View in: PubMed
    Score: 0,203
  16. Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunization. Expert Rev Vaccines. 2020 04; 19(4):383-393.
    View in: PubMed
    Score: 0,164
  17. Genomic differences among carriage and invasive nontypeable pneumococci circulating in South Africa. Microb Genom. 2019 10; 5(10).
    View in: PubMed
    Score: 0,158
  18. Performance of the Biomark HD real-time qPCR System (Fluidigm) for the detection of nasopharyngeal bacterial pathogens and Streptococcus pneumoniae typing. Sci Rep. 2019 04 24; 9(1):6494.
    View in: PubMed
    Score: 0,153
  19. The relative invasive disease potential of Streptococcus pneumoniae among children after PCV introduction: A systematic review and meta-analysis. J Infect. 2018 11; 77(5):368-378.
    View in: PubMed
    Score: 0,145
  20. Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S152-S159.
    View in: PubMed
    Score: 0,139
  21. Introduction of pneumococcal conjugate vaccine into the public immunization program in South Africa: translating research into policy. Vaccine. 2012 Sep 07; 30 Suppl 3:C21-7.
    View in: PubMed
    Score: 0,097
  22. Optimization of a high-throughput nanofluidic real-time PCR to detect and quantify of 15 bacterial species and 92 Streptococcus pneumoniae serotypes. Sci Rep. 2023 03 21; 13(1):4588.
    View in: PubMed
    Score: 0,050
  23. Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization. Microb Genom. 2022 06; 8(6).
    View in: PubMed
    Score: 0,048
  24. Upper airways colonisation of Streptococcus pneumoniae in adults aged 60 years and older: A systematic review of prevalence and individual participant data meta-analysis of risk factors. J Infect. 2020 10; 81(4):540-548.
    View in: PubMed
    Score: 0,042
  25. Serocorrelates of protection against infant group B streptococcus disease. Lancet Infect Dis. 2019 05; 19(5):e162-e171.
    View in: PubMed
    Score: 0,038
  26. Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine. J Clin Microbiol. 2018 07; 56(7).
    View in: PubMed
    Score: 0,036
  27. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S100-S111.
    View in: PubMed
    Score: 0,035
  28. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov 06; 65(suppl_2):S133-S142.
    View in: PubMed
    Score: 0,035
  29. Use of 2 pneumococcal common protein real-time polymerase chain reaction assays in healthy children colonized with Streptococcus pneumoniae. Diagn Microbiol Infect Dis. 2011 Aug; 70(4):452-4.
    View in: PubMed
    Score: 0,022
  30. An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol. 2010 Jan; 48(1):184-91.
    View in: PubMed
    Score: 0,020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.